【Pharmaceutical Network Market Analysis】In recent years, with the rapid development of the domestic pharmaceutical industry, the domestic pharmaceutical equipment industry has also caught a "free ride" and opened an accelerated development model
However, due to the late start of the domestic pharmaceutical equipment industry and the majority of small and medium-sized enterprises, the industry generally believes that there is still a long way to go to become a real pharmaceutical equipment power
The development power of the domestic pharmaceutical machinery industry lies in innovation, so that innovation "landed" into the focus of enterprises (Image source: Pharmaceutical Network) In this regard, analysts pointed out that in order for the domestic pharmaceutical equipment industry to truly embark on the road to a strong country, the local pharmaceutical machinery industry must become stronger and stronger, and innovation is essential
to make a deafening voice in the world.
Enterprises should continue to increase capital investment in technological innovation, pay attention to the introduction and training of high-end talents, build a talent training and directional transportation platform with universities, and provide funds and talent support
for enterprise innovation.
In fact, in recent years, in the process of continuous development of China's pharmaceutical equipment industry, innovation has been paid more and more attention
by pharmaceutical machine people.
It is reported that at present, many pharmaceutical equipment with R&D strength and capital in China are increasing investment in innovation and R&D to accelerate the development of
product performance and capacity expansion.
For example, the proportion of R&D investment in revenue of Chutian Technology has remained at a high rate of about 10% every year, and in the first three quarters of 2021, R&D investment increased by more than 60% year-on-year, reaching more than 300 million yuan
At present, under continuous innovation, Chutian Technology has successfully launched a number of new products
Dongfulong has also been increasing R&D investment in recent years, and in 2021, the company invested 285 million yuan in R&D, a year-on-year increase of 82.
2%, accounting for 6.
of operating income.
The number of R&D personnel increased from 396 (14.
88%) in 20 years to 677 (18.
in 21 years.
At present, the company through self-research and cooperative research and development and other forms to enhance its own research and development strength, has successively successfully developed a variety of core equipment, rich patent achievements, by the end of 21, the company has 1154 effective patent technology, 149 software copyrights, including 139 new authorized patents in 21 years
It is worth mentioning that Dongfulong also issued a prospectus
for issuing A-shares to specific targets in 2022 some time ago.
According to the announcement, the total amount of funds raised by issuing shares to specific objects will not exceed 3.
2 billion yuan (including the principal amount), which is intended to be used to invest in the biopharmaceutical equipment industry trial production center project, Jiangsu biomedical equipment industrialization base project, Zhejiang Dongfulong Biotechnology Co.
life science industrialization base project and supplementary working capital
Of course, in addition to continuous investment in product innovation, pharmaceutical equipment companies are also increasing their layout
in the recruitment and training of R&D talents.
It is reported that many pharmaceutical equipment companies with strength have made great efforts
For example, some companies have launched artisan training centers, and plan to train them into a reserve force in the company in 3-5 years through self-recruitment or school recruitment of students and inexperienced social
While improving the training mechanism, enterprises also set up cadre training courses specifically for professional talents, and invest millions of yuan in training expenses
At the same time, in order to facilitate the gathering of technical talents, companies have been set up in Guangzhou and Changsha
In addition, some enterprises have established "industry-university-research alliances" with universities to help the pharmaceutical equipment industry develop and improve
in the direction of normalization, institutionalization and standardization by strengthening exchanges and cooperation with schools.
It is worth mentioning that under the continuous investment, while the independent innovation strength of pharmaceutical enterprises is constantly improving, it is also complying with user needs and carrying out differentiated and personalized innovation to accelerate the development of
product performance and capacity expansion.
For example, at the moment when energy conservation and environmental protection are advocated, pharmaceutical equipment companies are accelerating the creation of green and environmentally friendly products; At the moment when automation and intelligent technology continue to popularize, pharmaceutical equipment is also advancing with the times to meet the needs of automatic control and intelligent production, help the pharmaceutical industry production more efficient, safe, and save labor costs
。 Conclusion Analysts believe that in the future, in the pharmaceutical equipment industry to continuously improve the industry-university-research cooperation mechanism, innovative scientific and technological achievements transformation mechanism, accelerate the construction of pharmaceutical equipment key technology research and development, scientific and technological information, technology transfer and other technical service platforms background, domestic pharmaceutical machinery enterprises in the transformation of innovation achievements are expected to become more and more obvious, China's pharmaceutical equipment industry in this context will also accelerate the development
of higher quality.
Disclaimer: Under no circumstances does the information or opinions expressed herein constitute investment advice